Amundi’s Bristol-Myers Squibb BMY Stock Holding History

Amundi’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$431M	Buy	7,474,537 +800,539	+12%	+$46M	0.1%	174
2026 Q1	$405M	Buy	6,673,998 +642,539	+11%	+$37.5M	0.11%	164
2025 Q4	$325M	Buy	6,031,459 +57,037	+1%	+$2.74M	0.09%	228
2025 Q3	$270M	Buy	5,974,422 +194,283	+3%	+$9.07M	0.09%	209
2025 Q2	$275M	Buy	5,780,139 +513,255	+10%	+$25.2M	0.1%	202
2025 Q1	$305M	Buy	5,266,884 +127,236	+2%	+$7.42M	0.11%	189
2024 Q4	$292M	Sell	5,139,648 -2,655,099	-34%	-$148M	0.1%	193
2024 Q3	$409M	Sell	7,794,747 -576,788	-7%	-$27.1M	0.15%	142
2024 Q2	$335M	Buy	8,371,535 +2,503,473	+43%	+$112M	0.13%	154
2024 Q1	$288M	Buy	5,868,062 +876,155	+18%	+$44.6M	0.12%	178
2023 Q4	$256M	Sell	4,991,907 -1,084,804	-18%	-$56.9M	0.12%	202
2023 Q3	$343M	Sell	6,076,711 -93,540	-2%	-$5.73M	0.17%	136
2023 Q2	$398M	Sell	6,170,251 -1,596,638	-21%	-$107M	0.2%	119
2023 Q1	$542M	Sell	7,766,889 -684,476	-8%	-$48.3M	0.29%	81
2022 Q4	$608M	Buy	8,451,365 +1,173,021	+16%	+$88.4M	0.33%	72
2022 Q3	$520M	Buy	7,278,344 +1,914,982	+36%	+$139M	0.31%	72
2022 Q2	$398M	Buy	5,363,362 +1,195,638	+29%	+$91.1M	0.32%	77
2022 Q1	$321M	Buy	4,167,724 +743,321	+22%	+$49.9M	0.22%	117
2021 Q4	$221M	Sell	3,424,403 -1,927,571	-36%	-$113M	0.14%	173
2021 Q3	$317M	Buy	5,351,974 +48,819	+0.9%	+$3.22M	0.22%	109
2021 Q2	$354M	Buy	+5,303,155	New	+$346M	0.25%	92

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi's BMY Position: Q2 2026 in Review

Amundi increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $46M and bringing the position to 7,474,537 shares worth $431M. The position accounts for 0.1% of the portfolio, ranked #174.

Amundi first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $608M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Amundi held 7,474,537 shares of Bristol-Myers Squibb worth $431M as of Q2 2026.
Amundi bought 800,539 Bristol-Myers Squibb shares in Q2 2026, an estimated $46M.
Bristol-Myers Squibb made up 0.1% of Amundi's portfolio in Q2 2026, its #174 holding.
Amundi first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
Amundi's Bristol-Myers Squibb position peaked at $608M in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.